drug therapy for asthma and bronchoconstriction Flashcards
bronchoconstrictive disorder
airway hyperresponsiveness, bronchoconstriction, inflammation, mucosal edema, excessive mucus production (asthma, bronchitis, emphysema)
asthma is caused by
genetic IgE hypersensitivity reaction, can occur at any age, more common in African American and hispanics
asthma is stimulated by
viral infections, environmental irritants, stress/ emotion, strenuous activity, temp/weather changes
pathophysiology of asthma
muscle constriction narrows airways, inflammatory response (mast cells, cytokines releases, inflammation)
what is considered mild to moderate asthma
recurrent and reversible
what is considered advanced or severe asthma
less revisable, chronic inflammation, structural changes
s/sx of asthma attack (bronchoconstriction, inflammation, hyperresponsiveness)
dyspnea, wheezing, chronic cough, peak expiratory flow rate decrease (PEFR), vary moderate to severe symptoms, acute flare lasts mins-hrs
what is status asthmaticus
acute severe asthma, doesn’t respond to usual treatments, severe respiratory distress, life threatening
two other bronchocontrictiive disorders similar to asthma are
chronic bronchitis and emphysema
what is chronic bronchitis
frequent productive cough more than 3 months/year x2 years, increased mucus leads to airway narrowing, chronic changes
what is emphysema
enlargement and destruction of alveoli r/t long term lung damage, loss of elasticity and surface area, carbon dioxide trapping
s/sx of chronic bronchitis
airway flow problem, cyanotic, recurrent cough & increased sputum production, hypoxia, hypercapnia (increased pCO2), respiratory acidosis, increased hub, high RR,
s/sx of emphysema
increase CO2 retention, minimal cyanosis, purse lip breathing, dyspnea, barrel chest, speaks in short jerky sentences, anxious, use of accessory muscles to breathe, thin appearance
chronic obstructive pulmonary disease (COPD) is what
a combination of chronic bronchitis and emphysema, usually develops with long standing exposure to airway irritants (ex. cigarette smoke)
symptoms of COPD
more constant/ less reversible, dyspnea, activity intolerance, air trapping in lungs
T or F. there re no long term side effects from asthma
false; chronic asthma leads to structural changes (fibrosis, enlarged smooth muscle cells, enlarged mucous glands) known as airway remodeling
patients with bronchoconstrictive disorders will report difficulty with which if the following?
exhaling; bronchoconstrictive disorders are known to make exhalation difficult because excess mucus and airway narrowing from inflammation makes it difficult for air to exit the alveoli (air trapping)
goals for bronchoconstrictive disorders
prevent airway inflammation, minimize use of “rescue drugs”
main treatments for bronchoconstrictive disorders
bronchodilators and anti-inflammatory
examples of bronchodilators
adrenergic, anticholinergics, xanthines
examples of anti-inflammatory
corticosteroids, leukotriene modifiers, most cell stabilizes, immunosuppressants
administering bronchodilators is most effective by
inhalation, and the treatment of first choice to relieve acute asthma
bronchoconstrictive disorder drugs used for asthma management
beta 2 adrenergic agonists
two general types of inhaled beta 2 adrenergic agonists
rescue inhalant and maintenance inhalant
what are rescue inhalants
medications used during periods of acute symptoms and exacerbations (quick relief, short acting drugs)
what are maintenance inhalants
medications used to achieve and maintain prophylactic control of persistent asthma (long term control drug)
example meds of beta 2 adrenergic agonists
albuterol (rescue) and salmeterol (maintenance)
beta 2 adrenergic agonists stimulate
beta adrenergic receptors in the smooth muscle of bronchi and bronchioles, stimulate production of cyclic AMP, the increase cyclic AMP produces bronchodilation